Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The No. 20 Concordia Bulldogs know an NAIA playoff berth could be waiting for them following Saturday’s regular-season finale ...